NCT00845221View on ClinicalTrials.gov

Glivec in Pediatric Chronic Myeloid Leukemia (CML)

PHASE4CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

November 30, 2011

Conditions
Chronic Myeloid Leukemia
Interventions
DRUG

Imatinib mesylate 100 mg (Glivec)

260 mg/m2/day tablets

Trial Locations (3)

13385

Hôpital La Timone - CHU de Marseille, Marseille

54511

Hôpital de Brabois - CHU de Nancy, Vendoeuvre Les Nancy

80000

CHU Amiens, Amiens

All Listed Sponsors
lead

Poitiers University Hospital

OTHER

NCT00845221 - Glivec in Pediatric Chronic Myeloid Leukemia (CML) | Biotech Hunter | Biotech Hunter